The document discusses a study from the ISCHEMIA trial that examined the relationships between ischemia severity, extent of coronary artery disease, and clinical outcomes. The study found that performing percutaneous revascularization plus optimal medical therapy versus optimal medical therapy alone in patients with moderate to severe ischemia and significant angiographic stenoses did not demonstrate an improvement in prognosis.

1. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías
Relationships Of Ischemia Severity
And Coronary Artery Disease
Extent With Clinical Outcomes
In The Ischemia Trial
Dr. David Maron

2. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías
Maron DJ, Hochman JS, Reynolds HR et al. N Engl J Med. 2020 Mar 30. doi: 10.1056/NEJMoa1915922

3. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías

4. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías

5. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías

6. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías
Guía ESC/EACTS 2018 sobre revascularización miocárdica. Rev Esp Cardiol. 2019;72(1):73.e1-e102

7. Relationships Of Ischemia Severity And Coronary
Artery Disease Extent With Clinical Outcomes
In The ISCHEMIA Trial
Pablo Toledo Frías
Conclusiones:
-la revascularización percutánea más tratamiento médico
óptimo frente al tratamiento médico óptimo en pacientes con
isquemia moderada severa y estenosis angiográficas
significativas no ha conseguido demostrar mejorar pronóstico